Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sana Biotechnology Inc (SANA) vs Zoetis Inc (ZTS) Price & Performance

Sana Biotechnology IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Sana Biotechnology Inc vs Zoetis Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Zoetis Inc is far larger — about 36.6× Sana Biotechnology Inc's market cap, and Zoetis Inc pays a 2.78% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.

SANAZTS
Market Cap
$873.84M$31.95B
Sector
HealthHealth
52-Week High
$5.92$156.76
52-Week Low
$2.68$71.91
Enterprise Value
$848.03M$39.24B
Dividend Yield
2.78%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS